Weight Loss Drug Belviq Pulled From Shelves After FDA Warns of Cancer Risk

A study designed to rule out heart-risk found a slightly higher incidence of cancer among those who took the drug for one year.

Published Feb 14, 2020

NOW
PLAYING
Heartburn Drug, Zantac, Flagged By FDA, Citing Cancer-Risk -- Requests Manufacturers To Withdraw It From The Market And Tells Consumers to Stop Taking It
NOW
PLAYING
Managing Chemotherapy Side Effects
NOW
PLAYING
Who Should Receive HIPEC for Ovarian Cancer?
NOW
PLAYING
Shannen Doherty's 'Stealing This Look': Why Cancer Patients Are Smart To Be Concerned About COVID-19 Infection
NOW
PLAYING
A Promising New Study Suggests Women with an Aggressive Form of Breast Cancer Could Benefit from Immunotherapy
NOW
PLAYING
Lung Screening With Low Dose CT Should Happen For All
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.